Acromegaly 2018 Global Market Analysis by Manufacturers, Trends, Segmentation and Opportunities Forecast to 2023

Pune, India, 23rd August 2018: WiseGuyReports announced addition of new report, titled “Acromegaly Market Research Report- Global Forecast Till 2023”.

Report Description
This report analyzes the global acromegaly market by types (ectopic acromegaly, acromegaly due to growth hormone), by diagnosis (medical imaging, medical laboratory investigations), by treatment (medications, surgery, radiation therapy), by end users (hospitals, clinics); it also studies the top manufacturers in the market.

The global acromegaly market is anticipated to grow at a CAGR of 5.2 % during the forecast period 2017-2023.


The major players in global acromegaly market include:
• Novartis AG (Switzerland)
• Aegis Therapeutics LLC (US)
• Chiasma Inc (US)
• Crinetics Pharmaceuticals Inc (US)
• Daewoong Pharmaceutical Co Ltd (South Korea)
• Peptron Inc (South Korea)
• Silence Therapeutics Plc (UK)
• Strongbridge Biopharma plc (US)
• Amryt Pharma plc (UK)
• Foresee Pharmaceuticals LLC (US)
• Glide Pharmaceutical Technologies Ltd (US)
• Ionis Pharmaceuticals Inc (US)
• Ipsen SA (France)

The market revenue and share have been analyzed with respect to the following regions and countries:
North America
Rest of Western Europe
Eastern Europe
Republic of Korea
Rest of Asia-Pacific
The Middle East & Africa
United Arab Emirates
Saudi Arabia
Rest of the Middle East & Africa

On the basis of types, the global acromegaly market has been categorized into the following segments:

• Ectopic Acromegaly
• Acromegaly Due to Growth Hormone
On the basis of diagnosis, the global acromegaly market has been categorized into the following segments:
• Medical Imaging
• Medical Laboratory Investigations

On the basis of treatment, the global acromegaly market has been categorized into the following segments:

• Medications
• Surgery
• Radiation Therapy

On the basis of end users, the global acromegaly market has been categorized into the following segments:

• Hospitals
• Clinics

Research Methodology
Analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data.

Table of Content: Key Points
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market DynamicChapter 5. Market Factor Analysis
Chapter 6. Global Acromegaly Market, By Type
Chapter 7. Global Acromegaly Market, By Diagnosis


Get in touch:

Contact Info:
Name: Norah trent
Email: Send Email
Address: Office No. 528, Amanora Chambers
Phone: +44 208 133 9349

Release ID: 397112